Directory
>
Anneleen Daemen
Anneleen Daemen
Executive Director of Translational Medicine | ORIC Pharmaceuticals Inc.
California, United States
Anneleen Daemen
Summary
Anneleen Daemen is a distinguished Executive Director of Translational Medicine at ORIC Pharmaceuticals, specializing in bioinformatics and biomarker discovery in oncology. With over 15 years of experience in translational research and next-generation sequencing, she has made significant contributions to understanding cancer heterogeneity and developing novel therapeutic strategies. Anneleen has a proven track record of leadership, having supervised teams and played key roles in various research initiatives. She is passionate about precision medicine and has authored over 80 peer-reviewed articles. Her academic background includes a PhD in Bioinformatics, and she has held prestigious positions at renowned institutions like Genentech. Anneleen is recognized for her innovative approach to integrating complex biological data to inform clinical development. She thrives in dynamic environments and is dedicated to advancing cancer research and patient care.
Anneleen Daemen
Work Experience
Executive Director of Translational Medicine at
ORIC Pharmaceuticals Inc.
August 2022 - Present
Senior Director of Translational Medicine at
ORIC Pharmaceuticals
October 2019 - September 2022
Senior Bioinformatics Scientist & Group leader at
Genentech
August 2018 - October 2019
Bioinformatics Scientist at
Genentech
July 2015 - July 2018
Computational Biologist at
Genentech
March 2012 - July 2015
Visiting professor in statistics, Department of Obstetrics and Gynecology at
Ku Leuven
July 2011 - December 2012
Postdoctoral fellow at
Ucsf Department Of Laboratory Medicine
September 2011 - February 2012
Postdoctoral fellow at
Berkeley Lab
September 2010 - August 2011
Postdoctoral researcher at
Katholieke Universiteit Leuven Department Of Electrical Engineering
June 2010 - August 2010
PhD candidate in clinical Bioinformatics at
Katholieke Universiteit Leuven Department Of Electrical Engineering
October 2006 - May 2010
Anneleen Daemen
Education
Ku Leuven Faculty Of Engineering Technology & Faculty Of Movement And Rehabilitation Sciences
January 1970 - January 1970
Lemmensinstituut Leuven (Belgium), Bachelor Of Music
January 1970 - January 1970
College Heilig Kruis St.Ursula 2
January 1970 - January 1970
Lemmensinstituut Leuven (Belgium), Bachelors
Frequently Asked Questions about Anneleen Daemen
What is Anneleen Daemen email address?
Anneleen Daemen's primary email address is ***************@oricpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Anneleen Daemen work for?
Anneleen Daemen is a Executive Director of Translational Medicine at ORIC Pharmaceuticals Inc., a company specializing in Commercial physical research.
Where Anneleen Daemen graduated from?
Anneleen Daemen holds a degree in from Ku Leuven Faculty Of Engineering Technology & Faculty Of Movement And Rehabilitation Sciences.
How can I directly contact Anneleen Daemen?
To contact Anneleen Daemen directly, you can use the email address ***************@oricpharma.com. Complete contact information is available upon registration with Muraena.
Is Anneleen Daemen an immigrant?
Yes, Anneleen Daemen is an immigrant and currently based in United States
Who is Anneleen Daemen?
Anneleen Daemen is a distinguished Executive Director of Translational Medicine at ORIC Pharmaceuticals, specializing in bioinformatics and biomarker discovery in oncology. With over 15 years of experience in translational research and next-generation sequencing, she has made significant contributions to understanding cancer heterogeneity and developing novel therapeutic strategies. Anneleen has a proven track record of leadership, having supervised teams and played key roles in various research initiatives. She is passionate about precision medicine and has authored over 80 peer-reviewed articles. Her academic background includes a PhD in Bioinformatics, and she has held prestigious positions at renowned institutions like Genentech. Anneleen is recognized for her innovative approach to integrating complex biological data to inform clinical development. She thrives in dynamic environments and is dedicated to advancing cancer research and patient care.
Anneleen`s contact details
***************@oricpharma.com
***************@esat.kuleuven.be
Colleagues
Board Member
Executive Director/Senior Director, Clinical Pharmacology
Vice President, Finance
Independent Board Member and Audit Committee Chair
Vice President, Head of People
VP of Finance
Vice President
VP, Head of CMC